American International Group, Inc. Praxis Precision Medicines, Inc. Transaction History

American International Group, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.8 - $4.98 $3,590 - $22,350	4,488 Added 24.22%	23,019 $18,000
Q4 2022 Feb 10, 2023	BUY	$1.88 - $36.45 $1,071 - $20,776	570 Added 3.17%	18,531 $44,000
Q3 2022 Nov 14, 2022	BUY	$2.5 - $37.95 $635 - $9,639	254 Added 1.43%	17,961 $41,000
Q2 2022 Aug 12, 2022	BUY	$1.75 - $11.34 $2,044 - $13,245	1,168 Added 7.06%	17,707 $43,000
Q1 2022 May 13, 2022	SELL	$10.21 - $20.29 $11,894 - $23,637	-1,165 Reduced 6.58%	16,539 $169,000
Q4 2021 Feb 11, 2022	SELL	$16.76 - $22.99 $452 - $620	-27 Reduced 0.15%	17,704 $349,000
Q3 2021 Nov 12, 2021	BUY	$13.15 - $22.56 $53,454 - $91,706	4,065 Added 29.75%	17,731 $328,000
Q2 2021 Aug 13, 2021	BUY	$18.28 - $33.05 $132,310 - $239,215	7,238 Added 112.6%	13,666 $250,000
Q1 2021 May 07, 2021	BUY	$29.34 - $60.2 $498 - $1,023	17 Added 0.27%	6,428 $211,000
Q4 2020 Feb 12, 2021	BUY	$27.25 - $55.82 $174,699 - $357,862	6,411 New	6,411 $353,000

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $3.54B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.